Cora Peterson1, Likang Xu2, Curtis Florence2, Karin A Mack2. 1. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. Electronic address: cora.peterson@cdc.hhs.gov. 2. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Abstract
OBJECTIVE: To classify and compare US nationwide opioid-related hospital inpatient discharges over time by discharge type: 1) opioid use disorder (OUD) diagnosis without opioid overdose, detoxification, or rehabilitation services, 2) opioid overdose, 3) OUD diagnosis or opioid overdose with detoxification services, and 4) OUD diagnosis or opioid overdose with rehabilitation services. METHODS: Survey-weighted national analysis of hospital discharges in the Healthcare Cost and Utilization Project National Inpatient Sample yielded age-adjusted annual rates per 100,000 population. Annual percentage change (APC) in the rate of opioid-related discharges by type during 1993-2016 was assessed. RESULTS: The annual rate of hospital discharges documenting OUD without opioid overdose, detoxification, or rehabilitation services quadrupled during 1993-2016, and at an increased rate (8% annually) during 2003-2016. The discharge rate for all types of opioid overdose increased an average 5-9% annually during 1993-2010; discharges for non-heroin overdoses declined 2010-2016 (3-12% annually) while heroin overdose discharges increased sharply (23% annually). The rate of discharges including detoxification services among OUD and overdose patients declined (-4% annually) during 2008-2016 and rehabilitation services (e.g., counselling, pharmacotherapy) among those discharges decreased (-2% annually) during 1993-2016. CONCLUSIONS: Over the past two decades, the rate of both OUD diagnoses and opioid overdoses increased substantially in US hospitals while rates of inpatient detoxification and rehabilitation services identified by diagnosis codes declined. It is critical that inpatients diagnosed with OUD or treated for opioid overdose are linked effectively to substance use disorder treatment at discharge.
OBJECTIVE: To classify and compare US nationwide opioid-related hospital inpatient discharges over time by discharge type: 1) opioid use disorder (OUD) diagnosis without opioid overdose, detoxification, or rehabilitation services, 2) opioid overdose, 3) OUD diagnosis or opioid overdose with detoxification services, and 4) OUD diagnosis or opioid overdose with rehabilitation services. METHODS: Survey-weighted national analysis of hospital discharges in the Healthcare Cost and Utilization Project National Inpatient Sample yielded age-adjusted annual rates per 100,000 population. Annual percentage change (APC) in the rate of opioid-related discharges by type during 1993-2016 was assessed. RESULTS: The annual rate of hospital discharges documenting OUD without opioid overdose, detoxification, or rehabilitation services quadrupled during 1993-2016, and at an increased rate (8% annually) during 2003-2016. The discharge rate for all types of opioid overdose increased an average 5-9% annually during 1993-2010; discharges for non-heroin overdoses declined 2010-2016 (3-12% annually) while heroinoverdose discharges increased sharply (23% annually). The rate of discharges including detoxification services among OUD and overdosepatients declined (-4% annually) during 2008-2016 and rehabilitation services (e.g., counselling, pharmacotherapy) among those discharges decreased (-2% annually) during 1993-2016. CONCLUSIONS: Over the past two decades, the rate of both OUD diagnoses and opioid overdoses increased substantially in US hospitals while rates of inpatient detoxification and rehabilitation services identified by diagnosis codes declined. It is critical that inpatients diagnosed with OUD or treated for opioid overdose are linked effectively to substance use disorder treatment at discharge.
Authors: Alexander Y Walley; Michael Paasche-Orlow; Eugene C Lee; Shaula Forsythe; Veerappa K Chetty; Suzanne Mitchell; Brian W Jack Journal: J Addict Med Date: 2012-03 Impact factor: 3.702
Authors: Elana S Rosenthal; Adolf W Karchmer; Jesse Theisen-Toupal; Roger Araujo Castillo; Chris F Rowley Journal: Am J Med Date: 2015-11-18 Impact factor: 4.965
Authors: Caroline A King; Ryan Cook; Haven Wheelock; P Todd Korthuis; Judith M Leahy; Amelia Goff; Cynthia D Morris; Honora Englander Journal: Int J Drug Policy Date: 2021-11-24
Authors: Caroline A King; Ryan Cook; P Todd Korthuis; Dennis McCarty; Cynthia D Morris; Honora Englander Journal: J Addict Med Date: 2022-02-08 Impact factor: 4.647
Authors: Susan L Calcaterra; Steve Lockhart; Catherine Callister; Kaitlyn Hoover; Ingrid A Binswanger Journal: J Gen Intern Med Date: 2022-01-03 Impact factor: 6.473